# DESCRIPTION

## STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT

- acknowledge government support

## FIELD OF THE INVENTION

- define invention scope

## BACKGROUND OF THE INVENTION

- discuss prior art limitations

## SUMMARY OF THE INVENTION

- introduce compound formula

## X2 is O or N,

- define compound structure

## DETAILED DESCRIPTION OF THE INVENTION

- describe compounds of formula (I)

### I. COMPOUNDS OF FORMULA (I)

- define compounds of formula (I)

### X2 is O or N,

- define R3 and R4
- specify embodiments of R7 and R8
- specify embodiments of R3 and R4
- specify embodiments of R9

### II. SUBSET OF COMPOUNDS OF FORMULA (IA)

- define carbamoyl moiety
- describe substituents R1-R8
- provide embodiments of compounds of Formula (Ia)

### III. SUBSET OF COMPOUNDS OF FORMULA (IB)

- define reverse-carbamoyl moiety
- describe substituents R1-R9
- provide embodiments of compounds of Formula (Ib)

### IV. DEFINITIONS

- define technical terms
- specify meaning of halogen and alkyl
- describe alkyl and cycloalkyl groups
- define heteroatom, heteroalkyl, and heterocycloalkyl
- define heteroaryl groups
- define aromatic ring and heteroaromatic ring
- define arylalkyl and related terms
- define substituents for alkyl, heteroalkyl, aryl, and heteroaryl groups
- define heterocycle and related terms

### V. PHARMACEUTICALLY ACCEPTABLE SALTS

- define pharmaceutically acceptable salts
- describe acid addition salts
- describe solvates and hydrates
- describe isotopically labelled compounds

### VI. MEDICAL USES OF COMPOUNDS OF FORMULA (I), (Ia), (Ib)

- describe medical uses of compounds
- describe inhibition of FAAH and COX enzymes
- describe treatment of diseases and disorders
- describe combination therapies

### VII. PHARMACEUTICAL COMPOSITIONS

- describe pharmaceutical compositions
- describe carriers and excipients
- describe dosage forms and administration routes

### VIII. METHODS FOR PREPARING COMPOUNDS OF FORMULA (I), (Ia), (Ib)

- introduce synthetic techniques for compounds of Formula (I), (Ia), (Ib)
- describe carbamoylation reaction of compounds of formula (II)
- outline methods for preparing compounds of formula (II)
- provide procedure for exemplary compounds according to Formula (I)
- describe purification techniques for compounds of Formula (I), (Ia), (Ib)
- illustrate examples of compounds according to Formula (I), (Ia) or (Ib)
- provide methods for testing compounds of the invention
- describe materials and methods
- outline general procedures for preparing compounds
- provide specific examples of compound preparation
- detail NMR and MS analysis of compounds
- report physical properties of compounds
- prepare compounds of formula (I), (Ia), (Ib)
- describe synthesis of various derivatives
- provide NMR and MS data for each compound
- detail purification methods for each compound
- prepare compounds of formula (I), (Ia), (Ib)
- synthesize intermediate compounds
- purify and characterize final compounds
- report NMR and MS data
- prepare compounds of formula (I), (Ia), (Ib)
- synthesize methyl 2-[3-fluoro-4-[3-(phenethylcarbamoyloxy)phenyl]phenyl]pro
- synthesize 2-[3-fluoro-4-[3-(phenethylcarbamoyloxy)phenyl]phenyl]propan
- synthesize other compounds of formula (I), (Ia), (Ib)
- prepare compounds of formula (I), (Ia), (Ib)
- synthesize derivatives using general methods B and D
- characterize compounds using NMR and MS
- report physical and spectral data
- prepare compounds of formula (I), (Ia), (Ib)
- synthesize various derivatives
- characterize compounds using NMR and MS
- describe enantiomers of Example 12

